Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (73 total)
-
Créateur: Boulanger, M., E. Molina, K. Wang, T. Kickler, Y. Xu, and B. T. Garibaldi.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-31
Description: Cytokines seen in severe COVID-19 are associated with proliferation, differentiation, and survival of plasma cells. Plasma cells are not routinely found in peripheral blood, though may produce virus-neutralizing antibodies in COVID-19 later in the… -
Créateur: NETEC
Sujet: Treatment & Care
Type d'élément: Webinaire
Date de la dernière mise à jour: 2021-05-21
Description: Webinar slides attached.Objectives: Discuss the epidemiology, pathology, symptoms, and diagnosis of Long COVID Describe options for treatment support for Long COVID Explain how the members of the team can provide psychological support for Long COVID… -
Créateur: Shaw, Robert H., Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S. Nguyen Van-Tam, and Matthew D. Snape.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-05-12
Description: There is significant international interest in heterologous prime-boost COVID-19 vaccination to mitigate against supply shocks or shortages that might otherwise reduce the speed of vaccine roll-out. Additionally, in light of changing recommendations… -
Créateur: Antar, Annukka A. R., Tong Yu, Nora Pisanic, Razvan Azamfirei, Jeffrey A. Tornheim, Diane M. Brown, Kate Kruczynski, Justin P. Hardick, Thelio Sewell, Minyoung Jang, Taylor Church, Samantha N. Walch, Carolyn Reuland, Vismaya S. Bachu, Kirsten…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-16
Description: Sustained molecular detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in the upper respiratory tract (URT) in mild to moderate coronavirus disease 2019 (COVID-19) is common. We sought to identify host and immune… -
Créateur: the Overcoming COVID-19 Investigators
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-06-16
Description: The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy. -
Créateur: Kadri, Sameer S., Junfeng Sun, Alexander Lawandi, Jeffrey R. Strich, Lindsay M. Busch, Michael Keller, Ahmed Babiker, Christina Yek, Seidu Malik, Janell Krack, John P. Dekker, Alicen B. Spaulding, Emily Ricotta, John H. Powers Iii, Chanu Rhee,…
Sujet: Emergency Management
Type d'élément: Publication
Date de la dernière mise à jour: 2021-07-06
Description: Several U.S. hospitals had surges in COVID-19 caseload, but their effect on COVID-19 survival rates remains unclear, especially independent of temporal changes in survival.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: The Medical Letter on Drugs and Therapeutics
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-07-15
Description: COVID-19 Vaccine Comparison Chart (online only) effectiveness by vaccine and by variant. -
Créateur: WHO
Sujet: General
Type d'élément: Lien hypertexte
Date de la dernière mise à jour: 2021-08-07
Description: This WHO fact sheet covers Marburg virus disease: Key facts Transmission Symptoms of Marburg virus disease Diagnosis Treatment and vaccines Marburg virus in animals Prevention and control Controlling infection in healthcare settings Marburg viral… -
Créateur: Barda, Noam, Noa Dagan, Yatir Ben-Shlomo, Eldad Kepten, Jacob Waxman, Reut Ohana, Miguel A. Hernán, Marc Lipsitch, Isaac Kohane, Doron Netzer, Ben Y. Reis, and Ran D. Balicer.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-08-25
Description: Preapproval trials showed that messenger RNA (mRNA)–based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile, yet these trials were subject to size and patient-mix limitations. An evaluation of the… -
Créateur: the COVID-19 Genomics UK (COG-UK) consortium
Sujet: Personnel Management
Type d'élément: Publication
Date de la dernière mise à jour: 2021-08-27
Description: The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March, 2021. It has since rapidly become the predominant lineage, owing to high transmissibility. It is suspected that the delta variant is associated with more severe disease…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.